U.S. Markets close in 5 hrs 9 mins

CAS Medical Systems, Inc. (CASM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.87-0.02 (-2.25%)
As of 9:30AM EDT. Market open.
People also watch
CRDCAHPIBVXCEMIBIOL

CAS Medical Systems, Inc.

44 East Industrial Road
Branford, CT 06405
United States
203-488-6056
http://www.casmed.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees96

Key Executives

NameTitlePayExercisedAge
Mr. Thomas M. Patton J.D.Chief Exec. Officer, Pres and Director502.28kN/A53
Mr. Jeffery A. BairdChief Financial Officer and Sec.311.25kN/A63
Mr. John K. Gamelin Ph.D.VP of R&D278.86kN/A52
Dr. Paul B. Benni Ph.D.Chief Scientific OfficerN/AN/A49
Susan CarronDirector of Corp. CommunicationsN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

CAS Medical Systems, Inc., a medical technology company, develops, manufactures, and markets non-invasive patient monitoring products worldwide. The company provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories, as well as offers FORE-SIGHT ELITE monitors; and traditional monitoring products, such as non-invasive blood pressure measurement technologies under the MAXNIBP and MAXIQ brand names, as well as provides monitor service and repair. It markets products through its own sales force, distributors, manufacturers’ representatives, and original equipment manufacturers, as well as through hospital, surgery center and outpatient facility, homecare, veterinary, and emergency medical distribution channels. CAS Medical Systems, Inc. was incorporated in 1984 and is headquartered in Branford, Connecticut.

Corporate Governance

CAS Medical Systems, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.